课题基金 / 基金详情

STRUCTURE AND FUNCTION OF HYALURONAN SYNTHASES

STRUCTURE AND FUNCTION OF HYALURONAN SYNTHASES
透明质酸合酶的结构和功能
批准号:
6930372
负责人:
PAUL H WEIGEL
金额:
$36.63万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-01-01 至 2007-07-31

项目摘要

项目成果

PAUL H WEIGEL的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):透明质酸(HA)是脊椎动物中普遍存在的细胞外基质成分,是细胞行为的强大调节剂,例如在细胞迁移、发育、癌症、伤口愈合和血管生成过程中。越来越多的证据表明,HA正常合成和降解的变化可能在关节炎和癌症等疾病的发病机制中起关键作用。指导这个项目的长期假设是,为了实现正常的动态平衡和健康,必须严格控制HA的合成。整个项目包括两个子项目,研究了HA的合成(由HA合成酶介导,我们是第一个克隆并纯化的小组)和HA周转(由HA内吞作用的受体介导)。由于这些子项目现在有了分子基础,并有了很大的扩展,它们被分成了两个独立的R01项目。目前的项目将继续研究链球菌和人类HA合成酶(HASS)。然而,HAS领域目前停滞不前的原因有两个:没有人能够提纯活性的原生人类Has,或者在其他两个人存在的情况下,没有人能够评估一个人的Has异构体的数量或活性。因此,我们推进这一领域的策略是使用链球菌HASS作为模型来理解人类HASS的功能。我们的具体假设是,对链球菌HASS的结构-功能分析将使我们能够了解人类HASS是如何工作的,以及HA的合成是如何调节的。我们将继续努力了解链球菌HASS,但也将利用我们所学到的知识来研究人类HASS。我们将使用生物化学、分子生物学和细胞生物学的技术来解决以下具体目标的多重假设。1)表征新合成的HA还原端的新型HA-UDP键。2)确定甲壳素-UDP寡聚体在HAS合成HA中的作用。3)鉴定激活海绵体的独特磷脂,并检测其对人体HASS的影响。4)分析链球菌HASS的结构与功能的关系。5)用EPR波谱确定SEHAS结构域的组织和运动。该项目的结果可能导致首次研究人类Has蛋白在各种病理和疾病中的作用,也可能导致开发治疗链球菌疾病的新药。
英文摘要
DESCRIPTION (provided by applicant): Hyaluronan (HA), which is a ubiquitous extracellular matrix component in vertebrates, is a powerful modulator of cell behavior, e.g. during cell migration, development, cancer, wound healing and angiogenesis. Accumulating evidence suggests that alterations in the normal synthesis and degradation of HA can be critical in the pathogenesis of diseases such as arthritis and cancer. The long-term hypothesis guiding this project is that HA synthesis must be tightly controlled in order to achieve normal homeostasis and health. The overall project has contained two sub-projects that have investigated HA synthesis (mediated by HA synthases, which we were the first group to clone and then to purify) and HA turnover (mediated by the HA Receptor for Endocytosis). Because these sub-projects now have a molecular basis and have greatly expanded, they are being split into two separate R01 projects. The current project will continue to study the streptococcal and human HA synthases (HASs). However, the HAS field is presently stalled for two reasons: no one has been able to purify an active native human HAS, or to assess the amount or activity of one individual HAS isoform in the presence of the other two. Consequently, our strategy to advance the field is to use the streptococcal HASs as a model to understand the functions of the human HASs. Our specific hypothesis is t hat structure-function analyses of the streptococcal HASs will allow us to understand how the human HASs work and how HA synthesis is regulated. We will continue efforts to understand the streptococcal HASs, hut also use what we learn to study the human HASs. We will employ techniques in biochemistry, molecular biology and cell biology to address multiple hypotheses in the following specific aims. 1) To characterize the novel HA-UDP linkage at the reducing end of newly synthesized HA. 2) To determine the role of chitin-UDP oligomers in HA synthesis by HAS. 3) To identify the unique phospholipids that activate seHAS and test their effects on human HASs. 4) To analyze structure-function relationships in the streptococcal HASs. 5) To determine the organization and motion of seHAS domains using EPR spectroscopy. Results from this project could lead to the first investigations of the roles of human HAS proteins in various pathologies and diseases and could also lead to the development of new drugs for streptococcal diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE-FUNCTION OF THE HA RECEPTOR FOR ENDOCYTOSIS
STRUCTURE-FUNCTION OF THE HA RECEPTOR FOR ENDOCYTOSIS
STRUCTURE-FUNCTION OF THE HA RECEPTOR FOR ENDOCYTOSIS
STRUCTURE-FUNCTION OF THE HA RECEPTOR FOR ENDOCYTOSIS
国内基金
海外基金
Streptococcus_salivarius 菌经肠肝轴定植肿瘤 微环境促进肝癌侵袭转移的分子机制研究
  • 批准号:
    Z24H160023
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈钢
  • 依托单位:
耳鼻咽喉头颈痛内菌Streptococcus mitis扰乱CAF细胞GSH代谢促进头颈鳞癌演进的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    只璟泰
  • 依托单位:
影响Streptococcus pyogenes CRISPR/Cas9脱靶的相关因素及其靶向特异性机制研究
  • 批准号:
    31770069
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2017
  • 负责人:
    孙宇辉
  • 依托单位: